| (210) | Number of the EPO application | 18749124 |
| (220) | Filing date of the EPO application | 2018.06.25 |
| (80) | EPO patent specification publication (B) | EPB nr. 46/2020, 2020.11.11 |
| (110) | EPO patent number | 3638370 |
| (11) | Number of the document | MD 3638370 T2 |
| (21) | Number of the application | e 2020 0433 |
| (71) | Name(s) of applicant(s), code of the country | INTRABIO LTD, GB, GB; |
| (72) | Name(s) of inventor(s), code of the country | STRUPP Michael, DE;
FACTOR Mallory, GB; |
| (73) | Name(s) of owner(s), code of the country | INTRABIO LTD, GB; |
| (54) | Title of the invention | Treatment of migraine with acetyl-leucine |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61P 25/06 (2006.01.01); A61K 31/198 (2006.01.01) |
| (19) | Country | GB |
| (41) | Date of publication of the application | 2020.05.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.04.30 |
| (74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |
| (86) | International application | PCT/IB2018/054676, 2018.06.25 |
| (87) | International publication | WO 2018/229738, 2018.12.20 |